Jove
Visualize
Contact Us

Related Experiment Videos

Pseudomyogenic hemangioendothelioma.

Nicholas A Horan1, Dominick J DiMaio2

  • 1Department of Physical Medicine and Rehabilitation, Carolinas Medical Center, Charlotte, North Carolina, USA.

Cutis
|January 24, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histidine decarboxylase inhibition attenuates cancer-associated muscle wasting.

The Journal of experimental medicine·2025
Same author

A Case of Bilateral Diffuse Uveal Melanocytic Proliferation Followed by Massive Unilateral Uveal Proliferation.

Ocular immunology and inflammation·2024
Same author

Differentiated mesenchymal stem cells-derived exosomes immobilized in decellularized sciatic nerve hydrogels for peripheral nerve repair.

Journal of controlled release : official journal of the Controlled Release Society·2024
Same author

Tumour extracellular vesicles and particles induce liver metabolic dysfunction.

Nature·2023
Same author

A Dual-network Nerve Adhesive with Enhanced Adhesion Strength Promotes Transected Peripheral Nerve Repair.

Advanced functional materials·2023
Same author

A Highly Efficacious Electrical Biofilm Treatment System for Combating Chronic Wound Bacterial Infections.

Advanced materials (Deerfield Beach, Fla.)·2022
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Pseudomyogenic hemangioendothelioma (PMHE) is a rare vascular tumor. This condition rarely metastasizes, offering an excellent long-term survival outlook for patients.

Area of Science:

  • Oncology
  • Pathology
  • Vascular Biology

Background:

  • Pseudomyogenic hemangioendothelioma (PMHE) is a rare vascular neoplasm recently incorporated into the World Health Organization classification of soft tissue tumors.
  • Distinguishing PMHE from other vascular tumors and its mimics is crucial for accurate diagnosis and patient management.

Observation:

  • PMHE exhibits a distinct clinical presentation and microscopic morphology.
  • This report details a specific patient case of PMHE, highlighting its unique characteristics.

Findings:

  • PMHE demonstrates a low metastatic potential, contrasting with some other vascular tumors.
  • Patients diagnosed with PMHE generally experience excellent long-term survival outcomes.

Implications:

Related Experiment Videos

  • Accurate histologic differentiation of PMHE from mimics like epithelioid sarcoma is essential.
  • Understanding PMHE's favorable prognosis guides clinical decision-making and patient counseling.